Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bio-Techne Q3 Adj $0.48 Beats $0.45 Estimate, Sales $303.43M Beat $292.19M Estimate

Author: Benzinga Newsdesk | May 01, 2024 06:31am
Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.45 by 6.67 percent. This is a 9.43 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $303.43 million which beat the analyst consensus estimate of $292.19 million by 3.85 percent. This is a 3.16 percent increase over sales of $294.15 million the same period last year.

Posted In: TECH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist